SHZ · 300725.SZ
PharmaBlock Sciences (Nanjing), Inc.
CN¥44.80+CN¥2.10 (+4.92%)
PharmaBlock Sciences (Nanjing), Inc.’s quoted price sits in the upper half of its reported 52-week range, 22.15% below the high.
Loading market information…
SHH · 688575.SS · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 07:00 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Shenzhen YHLO Biotech Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 36.71% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Shenzhen YHLO Biotech Co., Ltd.’s forward annual dividend is CN¥0.02 per share, paid annual. The forward yield is 0.2% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Shenzhen YHLO Biotech Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Shenzhen YHLO Biotech Co., Ltd. researches, develops, produces, sells, and services in vitro diagnostic instruments and reagents in China and internationally. The company offers chemiluminescence immunoassay analyzer, diabetes solution, automated biochemical analyzer, laboratory automation, tenfly phoenix blot analyzer, VISION Pro ESR analyzer, and VISION ESR analyzer. The company was founded in 2008 and is headquartered in Shenzhen, China.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:27 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥44.80+CN¥2.10 (+4.92%)
PharmaBlock Sciences (Nanjing), Inc.’s quoted price sits in the upper half of its reported 52-week range, 22.15% below the high.
CN¥19.09-CN¥0.70 (-3.54%)
Amoy Diagnostics Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 20.89% below the high.
CN¥12.46-CN¥0.04 (-0.32%)
Beijing Strong Biotechnologies, Inc.’s quoted price sits in the lower half of its reported 52-week range, 22.37% below the high.
CN¥15.01-CN¥0.83 (-5.24%)
TINAVI Medical Technologies Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 48.33% below the high.
CN¥8.14+CN¥0.07 (+0.87%)
Jiuzhitang Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 24.91% below the high.
CN¥12.29+CN¥0.17 (+1.4%)
Jiangsu Kanion Pharmaceutical Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 26.01% below the high.
CN¥19.75-CN¥0.30 (-1.5%)
Zhejiang Tianyu Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 28.96% below the high.
CN¥11.84+CN¥0.10 (+0.85%)
Edan Instruments, Inc.’s quoted price sits in the lower half of its reported 52-week range, 29.52% below the high.
